Show simple item record

dc.contributor.advisorSvendsen, Kristian
dc.contributor.authorLe, Truong An
dc.date.accessioned2024-11-19T08:35:32Z
dc.date.available2024-11-19T08:35:32Z
dc.date.issued2021-11-14
dc.description.abstractAntimicrobial resistance has long been a problem and a struggle to compromise as life-threatening infections are harder to treat. Among common pathogens, Klebsiella pneumoniae (K.pneumoniae) can be a highly resistant bacteria associated with increased mortality when infecting critically ill and immunocompromised patients. Prevalence of gastrointestinal carriage depends on several risk factors. Hospital stays and antibiotic use have been associated with K. pneumoniae carriage in the past, and several researchers have investigated how non-antibiotic drug use can alter the gut microbiome. Few have investigated non-antibiotic drug use as a potential risk factor. In this study we investigated if the use of antibiotic, non-antibiotic drugs and a combination of drugs can affect the gastrointestinal carriage of K. pneumoniae in terms of total exposure in defined daily dose (DDD), daily dosage and time of drug use. Our study population consisted of 2,997 participants aged ≥ 40 years from the seventh wave of the Tromsø Study: Tromsø 7 (2015-2016). Drug use data was acquired from the Norwegian Prescription Database (NorPD) and linked with data from Tromsø 7. We constructed treatment episodes with an allowed gap of 14 days and an assumption of 80% adherence and used logistic regression to analyze the different drugs as risk factors. We included the past six months for non-antibiotic and past two months for antibiotics in the analysis. Antacids (adjusted odds ratio 1.004, 95% Cl 1.001-1.006), antibiotics (1.027, 1.004-1.049), increasing age (1.016, 1.005-1.028), diabetes mellitus (2.467, 1.423-4.274) and Crohn’s disease/ulcerous colitis (2.367, 1.281-4.406) were factors based on total drug use exposure in DDD. As for daily dosage, antibiotics (1.949, 1.301-2.920), increasing age (1.018, 1.007-1.030) and having Crohn’s disease/ulcerous colitis (2.355, 1.271-4.363) were risk factors. We used a Venn diagram to illustrate the prevalence of carriage when a combination of drugs was used. The prevalence increased among those using two drugs and decreased when using three drugs of antacids, anti-inflammatory/antirheumatic drugs and antibiotics. Cumulative change graphs were used to illustrate the relationship between prevalence of carriage and last use of a drug group for the preceding 12 months. Antacid, thyroid drug, anti-inflammatory/antirheumatic drug and antibiotic users had a higher prevalence of K. pneumoniae carriage than the non-users, and the prevalence decreased for each month between last use of a drug group and fecal sample taken.en_US
dc.identifier.urihttps://hdl.handle.net/10037/35764
dc.language.isoengen_US
dc.publisherUiT Norges arktiske universiteten_US
dc.publisherUiT The Arctic University of Norwayen_US
dc.rights.accessRightsopenAccessen_US
dc.rights.holderCopyright 2021 The Author(s)
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0en_US
dc.rightsAttribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)en_US
dc.subject.courseIDFAR-3911
dc.subjectVDP::Medisinske Fag: 700::Helsefag: 800::Epidemiologi medisinsk og odontologisk statistikk: 803en_US
dc.subjectVDP::Medical disciplines: 700::Health sciences: 800::Epidemiology medical and dental statistics: 803en_US
dc.subjectVDP::Medisinske Fag: 700::Helsefag: 800::Andre helsefag: 829en_US
dc.subjectVDP::Medical disciplines: 700::Health sciences: 800::Other health science disciplines: 829en_US
dc.titleAssociations between use of antibiotic and non-antibiotic drugs on the gastrointestinal carriage of Klebsiella pneumoniae in a general adult population in Norwayen_US
dc.typeMaster thesisen_US
dc.typeMastergradsoppgaveen_US


File(s) in this item

Thumbnail
Thumbnail

This item appears in the following collection(s)

Show simple item record

Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)